Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis
Clinical trial NCT03073200 · COMPLETED
Trial details
- NCT number
- NCT03073200
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-28
- Primary completion
- 2019-02-07
- Enrollment
- 201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.